Defining the role of PET-CT in staging early breast cancer.

ABSTRACT:

Introduction

Currently, there is a lack of data on the role of combined positron emission tomography-computed tomography (PET-CT) in the staging of early invasive primary breast cancer. We therefore evaluated the role of (18)F-fluorodeoxyglucose ((18)F-FDG)-PET-CT in this patient population.

Methods

We prospectively recruited 70 consecutive patients (69 women, one man; mean age, 61.9 ± 8.1 years) with early primary breast cancer for staging with (18)F-FDG-PET-CT. All PET-CT images were interpreted by two readers (independently of each other). A third reader adjudicated any discrepancies. All readers had ≥5 years of specific experience. Ethics board approval and informed consent were obtained.

Results

The mean clinical follow-up was 22.7 ± 12.6 months. The primary tumo

SUBMITTER: Groves AM 

PROVIDER: S-EPMC3360901 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature